» Articles » PMID: 22835677

Adjustable Degradation and Drug Release of a Thermosensitive Hydrogel Based on a Pendant Cyclic Ether Modified Poly(ε-caprolactone) and Poly(ethylene Glycol)co-polymer

Overview
Journal Acta Biomater
Publisher Elsevier
Date 2012 Jul 28
PMID 22835677
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The convenient and precise fabrication of drug-hydrogel formulations with satisfactory degradability and a well-controlled drug release profile are crucial factors for injectable hydrogel formulations in clinical applications. Here a new injectable thermosensitive hydrogel formed from poly(ε-caprolactone) (PCL)-poly(ethylene glycol)-poly(ε-caprolactone) amphiphilicco-polymers with 1,4,8-trioxa[4.6]spiro-9-undecanone (TOSUO) moieties incorporated in the poly(ε-caprolactone) (PCL)block (PECT) was constructed to provide a route to tailor the degradation and drug release behavior. The effect of hydrophilic cyclic ether moieties on the degradation of and drug release by PECT hydrogels were evaluated in vitro and in vivo. The results indicated that a freeze-dried powder of paclitaxel-loaded PECT nanoparticles rapidly dissolved in water at ambient temperature with slightly shaking and formed a stable injectable in situ drug-hydrogel formulation at body temperature, which is convenient for clinical operations because it avoids the need for pre-quenching or long-term incubation. The paclitaxel distribution was also more quantitative and homogeneous on entrapping paclitaxel in PECT nanoparticles. Further, the small number of pendant cyclic ether groups in PCL could decrease the cystallinity and hydrophobicity and, as a result, the in vitro and in vivo retention time of PECT hydrogels and the release of entrapped paclitaxel could be tuned from a few weeks to months by varying the amount of PTOSUO in the hydrophobic block. Significantly, paclitaxel-loaded PECT nanoparticles and free paclitaxel could be simultaneously released during the in vitro paclitaxel release from PECT hydrogels. A histopathological evaluation indicated that in vivo injected PECT hydrogels produced only a modest inflammatory response. Thus pendant cyclic ether modification of PCL could be an effective way to achieve the desired degradation and drug release profiles of amphiphilicco-polymer thermosensitive hydrogels and PECT hydrogels may be suitable for local drug delivery.

Citing Articles

Hyaluronic-Acid-Nanomedicine Hydrogel for Enhanced Treatment of Rheumatoid Arthritis by Mediating Macrophage-Synovial Fibroblast Cross-Talk.

Wang Y, Wang J, Ma M, Gao R, Wu Y, Zhang C Biomater Res. 2024; 28:0046.

PMID: 38894889 PMC: 11185174. DOI: 10.34133/bmr.0046.


Thermosensitive hydrogel with programmed dual-octenidine release combating biofilm for the treatment of apical periodontitis.

Cheng Y, Huangfu Y, Zhao T, Wang L, Yang J, Liu J Regen Biomater. 2024; 11:rbae031.

PMID: 38605850 PMC: 11007118. DOI: 10.1093/rb/rbae031.


Codelivery of dihydroartemisinin and chlorin e6 by copolymer nanoparticles enables boosting photodynamic therapy of breast cancer with low-power irradiation.

Jia J, Chen W, Xu L, Wang X, Li M, Wang B Regen Biomater. 2023; 10:rbad048.

PMID: 37250978 PMC: 10224804. DOI: 10.1093/rb/rbad048.


Intelligent Hydrogels in Myocardial Regeneration and Engineering.

Doescher C, Thai A, Cha E, Cheng P, Agrawal D, Thankam F Gels. 2022; 8(9).

PMID: 36135287 PMC: 9498403. DOI: 10.3390/gels8090576.


Injectable thermo-responsive nano-hydrogel loading triptolide for the anti-breast cancer enhancement localized treatment based on "two strikes" effects.

Luo Y, Li J, Hu Y, Gao F, Leung G, Geng F Acta Pharm Sin B. 2020; 10(11):2227-2245.

PMID: 33304788 PMC: 7715064. DOI: 10.1016/j.apsb.2020.05.011.